These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22482746)

  • 41. Abnormal ductus venosus flow and tricuspid regurgitation at 11-14 weeks' gestation have high positive predictive values for increased risk in first-trimester combined screening test: results of a pilot study.
    Ozkaya O; Sezik M; Ozbasar D; Kaya H
    Taiwan J Obstet Gynecol; 2010 Jun; 49(2):145-50. PubMed ID: 20708518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.
    Westin M; Saltvedt S; Bergman G; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):632-9. PubMed ID: 16715530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nuchal translucency measurement--an effective method for early recognition of fetal disease?].
    Böhmer S; Lampe S; Blümel P
    Z Geburtshilfe Neonatol; 2003; 207(3):79-83. PubMed ID: 12891465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Increased nuchal translucency at 11-14 weeks of gestation in congenital heart disease, genetic syndromes and adverse pregnancy outcome].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Loquet P
    Akush Ginekol (Sofiia); 2005; 44(6):8-15. PubMed ID: 18982826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
    Faiola S; Tsoi E; Huggon IC; Allan LD; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 Jul; 26(1):22-7. PubMed ID: 15937972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased nuchal translucency in the presence of normal chromosomes: what's next?
    Alamillo CM; Fiddler M; Pergament E
    Curr Opin Obstet Gynecol; 2012 Mar; 24(2):102-8. PubMed ID: 22277886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
    Prats P; Ferrer Q; Comas C; Rodríguez I
    Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies.
    Sananes N; Guigue V; Kohler M; Bouffet N; Cancellier M; Hornecker F; Hunsinger MC; Kohler A; Mager C; Neumann M; Schmerber E; Tanghe M; Nisand I; Favre R
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):273-9. PubMed ID: 20069678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester.
    Geipel A; Willruth A; Vieten J; Gembruch U; Berg C
    Ultrasound Obstet Gynecol; 2010 May; 35(5):535-9. PubMed ID: 20183867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects.
    Timmerman E; Clur SA; Pajkrt E; Bilardo CM
    Ultrasound Obstet Gynecol; 2010 Dec; 36(6):668-75. PubMed ID: 20617506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early Evaluation of the Fetal Heart.
    Hernandez-Andrade E; Patwardhan M; Cruz-Lemini M; Luewan S
    Fetal Diagn Ther; 2017; 42(3):161-173. PubMed ID: 28675906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
    Kagan KO; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):42-7. PubMed ID: 25307357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fetal echocardiography at the time of the nuchal translucency scan.
    Lombardi CM; Bellotti M; Fesslova V; Cappellini A
    Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nuchal translucency and ductus venosus as ultrasound markers of chromosomal abnormalities].
    Díaz V; Guevara R; Brito J
    Invest Clin; 2008 Dec; 49(4):523-32. PubMed ID: 19245170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.